Tobacco Products and Cancer Policy Positions and Statements

The AACR regularly issues comments and position statements on federal policies related to tobacco control. Please see the links below for more information.

• AACR Joins Coalition Letter in Support of the Helping Tobacco Users Quit Act (September28, 2023)
• AACR Provides Comments on HHS 2023 Draft Framework to Support and Accelerate Smoking Cessation (July 30, 2023)
• AACR and ASCO Publish Updated Joint Policy Statement on Electronic Nicotine Delivery Systems (October 26, 2022)
• AACR Comment Supports Prohibiting Menthol Cigarettes (July 27, 2022)
• AACR Comment Supports Prohibiting Flavored Cigars and Other Flavored Combustible Tobacco Products (July 27, 2022)
• AACR Provides Comments on CMS Proposed Coverage Decision for Lung Cancer Screening and Smoking Cessation (December 16, 2021)
• AACR Joins Coalition Letter Urging FDA to Ban Menthol and All Other Non-Tobacco Flavored Tobacco Products (March 3, 2021)
• AACR Joins Coalition Letter Supporting FY 21 Appropriations for the CDC’s Office on Smoking and Health (December 2, 2020)
• AACR Joins Coalition Letter to the FDA Supporting a Ban on Menthol Cigarettes (November 9, 2020)
• AACR Joins Coalition Letter in Support of S. 4524, the Quit Because of COVID-19 Act (August 13, 2020)
• AACR Joins Coalition Letter Supporting H.R. 7286, the Quit Because of COVID-19 Act (July 10, 2020)
• AACR Joins Coalition Letter Opposing Provisions in the FY 21 FDA Appropriations that would weaken FDA Oversight Over Cigars (July 7, 2020)
• AACR Joins Coalition Letter to the FDA Urging Disclosure of Premarket Application Data (April 23, 2020)
• Petition Letter in Support of HR2339, the Reversing the Youth Tobacco Epidemic Act of 2019 (February 4, 2020)
• AACR Comments on Graphic Cigarette Warnings (October 15, 2019)
• AACR Submits Comments to FDA Draft Guidance Regarding Modifications to Compliance Policy for Certain Deemed Tobacco Products (April 30, 2019)
• The AACR Provides Comments on FDA Public Hearing Regarding Eliminating Youth E-Cigarette and Other Tobacco Product Use (Feb. 1, 2019)
• AACR and ASCO letter to FDA Commissioner Scott Gottlieb on Regulation of Premium Cigars (July 25, 2018)
• AACR and ASCO letter to FDA Commissioner Scott Gottlieb on Regulation of Flavors in Tobacco Products (July 19, 2018)
• Comments to the FDA on Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (July 16, 2018)
• Comments to CMS on Proposed Rule to Update Prospective Payment Rates for Medicare Inpatient Hospital Services Provided by Inpatient Psychiatric Facilities (June 26, 2018)
• Letter to FDA Commissioner Scott Gottlieb on Limiting Nicotine in Cigarettes to to Non-Addictive or Minimally Addictive Levels (May 21, 2018)
• Comments to the FDA on Nicotine Steering Committee Establishment of a Public Docket (April 13, 2018)
• Comments to the FDA on Nicotine Replacement Therapies (Feb. 15, 2018)
• Presentation to the FDA on Nicotine Replacement Therapies (Jan. 26, 2018)
• AACR, ASCO, and IASLC urge President Obama to help advance the FDA’s “deeming” regulation over tobacco products (May 2, 2016)
• AACR and ASCO Publish Joint Policy Statement on Electronic Nicotine Delivery Systems (February 1, 2015)
• AACR and ASCO Urge FDA to Regulate E-Cigarettes, Cigars, and Other Tobacco Products (Aug. 8, 2014)
• AACR and ASCO Urge FDA to Ban Menthol Cigarettes (Nov. 22, 2013)
• Citizen Petition to the FDA Requesting Ban of Menthol Flavoring in Tobacco (April 12, 2013)